Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...
The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...
A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...
State-funded clinical study will validate the OTraces’ proteomic blood test ability to reduce unnecessary prostate biopsies in men with elevated PSADEERFIELD BEACH, Fla., June 25, 2026 (GLOBE NEWSWIRE ...
To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...
Tempus AI (NasdaqGS:TEM) has launched the ArteraAI Prostate Test, its first externally developed AI-powered digital pathology test for metastatic hormone-sensitive prostate cancer. The test is ...
The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...